|
Orthologous residues
|
|
Cdc25B (human): S375‑p, Cdc25B iso2 (human): S361‑p, Cdc25B iso3 (human): S334‑p, Cdc25B (mouse): S372‑p, Cdc25B (rat): S370‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
DF1 (fibroblast), HeLa (cervical)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
SB202190, UV
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
14-3-3 beta (human)
|
|
Induces
|
|
|
electrophoretic visualization, co-immunoprecipitation
|
|